Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Pain 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphoma 1Leukemia 1

Interventions

Cyclophosphamide 75fludarabine phosphate 73Peripheral Blood Stem Cell Transplantation 59Mycophenolic Acid 53Tacrolimus 51Whole-Body Irradiation 48Busulfan 42Antilymphocyte Serum 40Cyclosporine 38Filgrastim 32fludarabine 31Methotrexate 30Melphalan 29Radiotherapy 22Methylprednisolone 18Cord Blood Stem Cell Transplantation 17Etoposide 16Sirolimus 14Alemtuzumab 13Flow Cytometry 12Cyclosporins 12thymoglobulin 11Granulocyte Colony-Stimulating Factor 11Cytarabine 10Psychiatric Rehabilitation 9sargramostim 8Thiotepa 8Rituximab 8Therapeutics 7Stem Cell Transplantation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myeloproliferative Disorders × Baclofen × Lymphoid × Clear all
NCT00516503 2017-08-24

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
208 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Pain, Neurotoxicity Syndromes, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡